Estimates of the severity of coronavirus disease 2019: a model-based analysis

[1]  S. Marks,et al.  Renal dysfunction in hospitalised children with COVID-19 , 2020, The Lancet Child & Adolescent Health.

[2]  Bruce Guthrie,et al.  Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study , 2020, The Lancet Global Health.

[3]  F. Finucane,et al.  Coronavirus and Obesity: Could Insulin Resistance Mediate the Severity of Covid-19 Infection? , 2020, Frontiers in Public Health.

[4]  Yongsheng Wu,et al.  Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study , 2020, The Lancet Infectious Diseases.

[5]  G. Dropkin.  COVID-19 UK Lockdown Forecasts and R0 , 2020, Frontiers in Public Health.

[6]  J. Carcione,et al.  A Simulation of a COVID-19 Epidemic Based on a Deterministic SEIR Model , 2020, Frontiers in Public Health.

[7]  Yongsheng Wu,et al.  Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts , 2020, medRxiv.

[8]  K. Kim,et al.  What Is COVID-19? , 2020, Frontiers for Young Minds.

[9]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[10]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[11]  S. Zhang,et al.  Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series , 2020, BMJ.

[12]  Novel Coronavirus Pneumonia Emergency Response Epidemiol Team.  [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[13]  Wei Liu,et al.  Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China , 2020, medRxiv.

[14]  N. Linton,et al.  Real-Time Estimation of the Risk of Death from Novel Coronavirus (COVID-19) Infection: Inference Using Exported Cases , 2020, Journal of clinical medicine.

[15]  Ting Yu,et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[16]  Jing Zhao,et al.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.

[17]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[18]  S. Lo,et al.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster , 2020, The Lancet.

[19]  Benjamin J Cowling,et al.  Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[20]  Peng Wu,et al.  Relative incidence and individual-level severity of seasonal influenza A H3N2 compared with 2009 pandemic H1N1 , 2017, BMC Infectious Diseases.

[21]  S. Moore,et al.  Estimating the Severity and Subclinical Burden of Middle East Respiratory Syndrome Coronavirus Infection in the Kingdom of Saudi Arabia , 2016, American journal of epidemiology.

[22]  M. Hernán,et al.  Potential Biases in Estimating Absolute and Relative Case-Fatality Risks during Outbreaks , 2015, PLoS neglected tropical diseases.

[23]  Benjamin J. Cowling,et al.  Epidemiological Characteristics of 2009 (H1N1) Pandemic Influenza Based on Paired Sera from a Longitudinal Community Cohort Study , 2011, PLoS medicine.

[24]  Benjamin J Cowling,et al.  A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan , 2010, BMC infectious diseases.

[25]  Simon Cauchemez,et al.  Assessing the severity of the novel influenza A/H1N1 pandemic , 2009, BMJ : British Medical Journal.

[26]  A. Ghani,et al.  CASEFAT: Stata module for estimating the case fatality ratio of a new infectious disease , 2009 .

[27]  G. Leung,et al.  Methods for Estimating the Case Fatality Ratio for a Novel, Emerging Infectious Disease , 2005, American journal of epidemiology.

[28]  C. Fraser,et al.  Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong , 2003, The Lancet.

[29]  中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组.  The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China./ 新型冠状病毒肺炎流行病学特征分析 , 2020 .

[30]  G. Chowell,et al.  Early epidemiological assessment of the transmission 1 potential and virulence of 2019 Novel Coronavirus in 2 Wuhan City: China, 2019–2020 , 2020 .

[31]  Takashi Ito.  Examination of Frequency and Nature of Side Effects Caused by Over-The-Counter Kampo Formulations Based on the Data Published by the Japanese Ministry of Health, Labour and Welfare , 2016 .

[32]  中華人民共和国国家統計局.  China statistical yearbook , 1988 .